skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i,
Happy New Year.
In the original asset allocator there was a suggested portfolio in ETFs. Mine has vanished! I was trying to look up possible ETFs in European or International small caps.
Are there any? Or would GIB, WSP,Altus or CAE count as international as well as Canadian?
Constance
Read Answer Asked by Constance on January 09, 2020
Q: Hi Gang, I am interested in buying one of this etf. Iwo, iwf,iwd, or Dia which one would you buy today. Our any other suggestion. Reasons? 3-5 years. Thanks
Alnoor
Read Answer Asked by Alnoor on January 09, 2020
Q: Could A&W be considered a candidate to be bought out by someone like MTY group or anyone else
Thks
Marse
Read Answer Asked by Marcel on January 09, 2020
Q: I am purchasing a house in the U.S. and will be converting a substantial amount of CDN $. Am looking at using DLR.TO etf to facilitate Norbert’ s Gambit using Scotia ITrade..I will also be talking to Scotiabank to see what they would cost.
What source do I use to determine actual exchange rate instead of relying on BNS info? Is Knightsbridge an alternative? Are there better avenues to use for NG than DLR ?What are the risks using NG?
I find all this rather intimidating and appreciate your advice, and also other people’s advice. How would I access previous question on this matter? Thanks , Derek
Read Answer Asked by Derek on January 09, 2020
Q: Looking at a 3 to 5 year time horizon, please rank the above companies as to total growth prospects. Thanks again. RAM
Read Answer Asked by Ray on January 09, 2020
Q: Hi 5i team!

What is your opinion of HLS these days?
I last asked about them in Feb 2019. At the time you were concerned about their debt level. Has it improved (marginally or otherwise) since then or do you foresee any further improvement in 2020 and beyond based on their recent financials?
They had a good 2019 wrt stock price appreciation.
They have recently received approval from Health Canada re Vascepa but significant sales from that drug may not occur for a year or 2 (or more).
Can this be added to an already diversified portfolio of mid caps? I recently took a 1/4 position in mid Dec at $19.34. I would like to add a further 1/4 position each quarter going forward. This will allow me to monitor their overall progress wrt their additional drug portfolio.
They stated that peak sales of Vascepa may not occur until 2-4 years thus the patient accumulation.

Cheers,
Steve
Read Answer Asked by Stephen on January 09, 2020
Q: How come when I try to search for BOSS in your Company section I get Apple?
Read Answer Asked by Earl on January 09, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!